Full Text

Turn on search term navigation

© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background

Lifestyle is associated with meningioma risk in the general population.

Aims

We assessed longitudinal associations between lifestyle‐associated factors and subsequent meningiomas in childhood cancer survivors.

Methods and results

Childhood cancer survivors age ≥18 years in the St. Jude Lifetime Cohort Study were evaluated for body composition, self‐reported physical activity, cardiopulmonary fitness, muscle strength, smoking, and alcohol consumption at baseline. Time to first meningioma analyses were performed, adjusted for sex, age at diagnosis and baseline assessment, treatment decade, and childhood cancer treatment exposures. The study included 4,072 survivors (47% female; [mean (SD)] 9 (6) years at diagnosis; 30 (8.5) years at the start of follow‐up, with 7.0 (3.3) years of follow‐up). 30% of the participants were survivors of acute lymphoblastic leukemia and 29% of the participants had received cranial radiation. During follow‐up, 90 participants developed ≥1 meningioma, of whom 73% were survivors of acute lymphoblastic leukemia, with cranial radiation being the strongest risk factor (relative risk [RR] 29.7, 95% confidence interval [CI] 10.6‐83.2). Muscle strength assessed by knee extension was associated with a lower risk of developing a meningioma in the adjusted analyses (RR 0.5, 95% CI 0.2‐1.0, p = 0.04 for quartiles 3‐4 vs. 1). No other lifestyle‐associated variable was associated with subsequent meningioma.

Conclusion

Independent of cranial radiation, muscle strength was associated with a lower risk of developing a subsequent meningioma in childhood cancer survivors.

Details

Title
Lifestyle and subsequent meningioma in childhood cancer survivors: A report from the St. Jude Lifetime Cohort study
Author
Onerup, Aron 1   VIAFID ORCID Logo  ; Mirzaei S., Sedigheh 2   VIAFID ORCID Logo  ; Bhatia, Shalini 2 ; Ware, Megan E. 3 ; Joffe, Lenat 4   VIAFID ORCID Logo  ; Turcotte, Lucie M. 5 ; Goodenough, Chelsea G. 3   VIAFID ORCID Logo  ; Sapkota, Yadav 3 ; Dixon, Stephanie B. 6   VIAFID ORCID Logo  ; Wogksch, Matthew D. 3 ; Ehrhardt, Matthew J. 6 ; Armstrong, Gregory T. 3 ; Hudson, Melissa M. 6 ; Ness, Kirsten K. 3 

 Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 
 Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee, USA 
 Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, Tennessee, USA 
 Department of Pediatrics, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA 
 Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA 
 Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA 
Section
ORIGINAL ARTICLES
Publication year
2024
Publication date
Jan 1, 2024
Publisher
John Wiley & Sons, Inc.
e-ISSN
25738348
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3090227709
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.